The SII not only produces most of the vaccines for India – it is also responsible for many of the vaccines distributed to the rest of the world. In September last year, SII pledged to manufacture and deliver 200 million doses for COVAX. But SII has had to halt or delay its exports several times in recent months as global and domestic demand surged.
User login
Language
Anonymous's groups in this site
User is not a member of any group.
Your groups across all your sites
User is not a member of any group.
Recent Content
Who's online
There are currently 0 users online.
You are here
Vaccine deliveries will be delayed from Serum Institute of India and AstraZeneca
Primary tabs
Thu, 2021-03-25 17:40 — mike kraft
Deliveries of Covid-19 vaccines produced by the Serum Institute of India (SII) to countries participating in the COVAX program will be delayed during March and April, Gavi, The Vaccine Alliance, announced in a news release on Thursday.
COVAX is a global vaccine-sharing initiative aimed at reducing vaccine inequality with discounted or free doses for lower-income countries.
The news release cited the government of India’s battle with a new wave of Covid-19 infections as the reason for the delay. On Wednesday, India's Ministry of Health announced it had discovered a new "double mutant" variant of Covid-19, as the country struggles to contain a spike in cases that's raising fears of a second wave.
“COVAX and the Government of India remain in discussions to ensure some supplies are completed during March and April,” the release said.
Gavi said according to its agreement with SII it is “contracted to provide COVAX with the SII-licensed and manufactured AstraZeneca (AZ)-Oxford vaccine (known as COVISHIELD) to over 60 lower-income economies participating in the Gavi COVAX AMC (including India), alongside its commitments to the Government of India.” ...
Country / Region Tags:
Problem, Solution, SitRep, or ?:
Groups this Group Post belongs to:
- Private group -
Recent Comments